GPR119 and type 2 diabetes mellitus: 3-O-MG PIC (1), as a GRP119 agonist with a new structural type exhibited strong GPR119 agonism and insulin secretion-stimulating activity at low concentration, suggesting that metabolite 1 was a promising candidate molecule for the treatment of T2DM, and in vivo activity is being evaluated.